Anteris Technologies Global Corp.

NASDAQ:AVR

Medical - Devices

Healthcare
$5.21 -0.16%

-$0.02 today

Market cap
$507.94M
Beta
0.73
P/E (TTM)
-2.3
EPS (TTM)
-$4.04
52W Low $2.85High $10.14

Volume 1.24M

Average 1.18M

AVR Other Stockholders Equity

Equity items not reported separately, such as additional paid-in capital or treasury stock.

Anteris Technologies Global Corp.NASDAQ: AVR

Other Stockholders Equity · Q1 FY2026 · quarter ended Mar 2026

Other stockholders equity turns positive

Q1 FY2026 other stockholders equity was $0, compared with -$1 a year earlier.

Context

  • Other stockholders equity amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Other stockholders equity increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether other stockholders equity keeps rising in the next quarterly balance sheet after a +100.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
-$1+100.0% since
Other Stockholders Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+100.0%——
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Stockholders Equity history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Other Stockholders Equity vs competitors

How AVR compares with its peers on the latest reported figures

  • AVR's Mar 2026 other stockholders equity of $0 is the 2nd highest of the 6 companies compared; the peer median is $0.
  • Its year-over-year change of +100.0% is the highest of 2, against a peer median of -103.6%.
  • Other stockholders equity amounts to 0.0% of total assets for AVR, versus a peer median of 0.0%.
AVR Competitors Peer median
Other Stockholders Equity for AVR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
LIVNLivaNova PLCSep 2026$1.37B ——50.6%
AVRAnteris Technologies Global Corp.Mar 2026$0 +100.0%—0.0%
BSXBoston Scientific CorporationJun 2026$0 ——0.0%
EWEdwards Lifesciences CorporationJun 2026$0 ——0.0%
AORTArtivion, Inc.Mar 2026$0 ——0.0%
MDTMedtronic plcJul 2026-$1M -103.6%—0.0%
Peer median (excluding AVR) $0-103.6%—0.0%

Competitors are the stored peer set for AVR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents15.46M9.29M21.03M70.46M12.58M
Short-term Investments00000
Net Receivables1.85M1.51M1.85M383K32K
Inventory549.82K355.62K442.35K513K735K
Other Current Assets1.65M60.13K61.66K2.66M1.69M
Total Current Assets18.75M12.24M24.22M74.65M15.68M
Property, Plant & Equipment (Net)1.92M3.14M5.48M5.86M7.26M
Goodwill00000
Intangible Assets763.64K607.35K410.15K189K65K
Long-term Investments00000
Tax Assets00000
Other Non-current Assets00417.27K00
Total Non-current Assets2.68M3.75M6.31M6.05M7.32M
Total Assets21.43M15.99M30.53M80.7M23M
Account Payables2.23M1.73M3.14M5.89M11.09M
Short-term Debt3.38M513.01K668.92K3K582K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities1.81M1.57M1.77M1.44M4.21M
Total Current Liabilities10.2M6.05M9.46M16.56M21.37M
Long-term Debt000022K
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities406.54K467.26K1.25M812K177K
Total Non-current Liabilities712.36K907.04K2.17M1.46M1.88M
Total Liabilities10.91M6.95M11.63M18.02M23.25M
Common Stock141.47M169.79M217.33M4K4K
Retained Earnings(123.51M)(154.07M)(200.1M)(276.39M)(370.53M)
Accumulated OCI(7.75M)(9.94M)(9.56M)(10.89M)(10.28M)
Other Stockholders Equity00000
Minority Interest00(402.84K)(79K)(160K)
Total Equity10.52M9.03M18.9M62.68M(253K)
Total Debt4.14M952.79K1.6M1.4M2.28M
Net Debt(11.32M)(8.34M)(19.43M)(69.06M)(10.29M)

Anteris Technologies Global Corp.

NASDAQ:AVR

Intrinsic Alpha fair value

Locked

Current Price

$5.21

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.